Edwards Lifesciences (EW.N) on Monday said it has agreed to sell its critical care products unit to Becton Dickinson (BDX.N) in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,